Bloomsbury Pharma AI vs CytoReason
Bloomsbury Pharma AI vs CytoReason, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Bloomsbury Pharma AI is on 33/100 and CytoReason on 68/100.
Where each one leads
Bloomsbury Pharma AI
Leads on none of the measures we hold for both companies.
CytoReason
- our overall score: 68/100 against 33/100
- headcount: 116 against 2
- headcount growth: +13.7% against -9.0%
- LinkedIn following: 12,830 against 133
At a glance
| Measure | Bloomsbury Pharma AI | CytoReason |
|---|---|---|
| What it is | AI and Big Data platform for identifying new drug indications and accelerating drug discovery. | Develops a computational model of the human body for drug discovery and development. |
| Category | Healthcare, Drug Discovery, AI Drug Discovery, Biotech | Healthcare, Drug Discovery, Clinical Development, Biomarkers |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Software |
| Founded | 2020 | 2016 |
| Headquarters | Not published | Tel Aviv, Israel |
| Status | Inactive | Active |
Size, funding and growth
| Measure | Bloomsbury Pharma AI | CytoReason |
|---|---|---|
| Employees | 2 | 116 |
| Headcount growthLast 12 months | -9.0% | +13.7% |
| Total funding | Not published | $128M |
| Latest round | Bootstrapped | Series B |
| LinkedIn followers | 133 | 12,830 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Bloomsbury Pharma AI | CytoReason |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 33/100 | 68/100 |
| Traction | 6/100 | 60/100 |
| Team | 60/100 | 70/100 |
| Search visibility | 21/100 | 30/100 |
| Quality | Not published | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | Not published | F (21/100) |
| Domain ratingLink authority, 0-100 | Not published | 40/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Bloomsbury Pharma AI | CytoReason |
|---|---|---|
| Analytics | Not detected | Segment |
What users say
| Measure | Bloomsbury Pharma AI | CytoReason |
|---|---|---|
| Community ratingVisitor votes on StartupHub | 5.0/5 from 1 vote | Not published |
Bloomsbury Pharma AI vs CytoReason: common questions
Which is better, Bloomsbury Pharma AI or CytoReason?
On our 0-100 score CytoReason rates higher (68/100 against 33/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do Bloomsbury Pharma AI and CytoReason compare on the numbers?
CytoReason leads on our overall score (68/100 against 33/100), headcount (116 against 2), headcount growth (+13.7% against -9.0%), LinkedIn following (12,830 against 133).
Read the full Bloomsbury Pharma AI review and pricing or the CytoReason review and pricing. You can also browse other Bloomsbury Pharma AI alternatives we track.